A study identified that the enhanced expression of SERPINA3 stimulated the bone environment by promoting osteoblasts and osteoclasts activation, suggesting that it may serve a diagnostic biomarker for PCa with bone metastasis phenotype and survival (Ito et al., 2023). Here, SERPINA3 is linked to posterior cortical atrophy.